Page 9

Semester 3: Pharmaceutical Biochemistry and Toxicology

  • Pharmacology: physico-chemical properties of drugs, drug absorption mechanisms, isomerism and pharmacological activity

    Pharmacology: Physico-Chemical Properties of Drugs, Drug Absorption Mechanisms, Isomerism and Pharmacological Activity
    • Physico-Chemical Properties of Drugs

      The physico-chemical properties of drugs such as solubility, pH, lipophilicity, and molecular weight significantly influence their pharmacokinetics and pharmacodynamics. These properties determine the drug's behavior in biological systems, including formulation, distribution, and interaction with biological receptors.

    • Drug Absorption Mechanisms

      Drug absorption is a critical process that affects the bioavailability of a drug. Various mechanisms include passive diffusion, facilitated diffusion, active transport, and endocytosis. Factors influencing absorption include drug formulation, route of administration, and physiological conditions within the body.

    • Isomerism in Drugs

      Isomerism refers to the existence of compounds with the same molecular formula but different structural arrangements. Types of isomerism include structural isomerism and stereoisomerism. Each isomer may exhibit different pharmacological effects and can lead to variability in therapeutic response and side effects.

    • Pharmacological Activity and Structure-Activity Relationship (SAR)

      Pharmacological activity of a drug is influenced by its chemical structure, which can affect its interaction with biological targets. The structure-activity relationship (SAR) is a key concept in medicinal chemistry that helps in understanding and predicting how modifications to a drug's structure can alter its pharmacological activity.

  • Drug designing: molecular modeling, computational chemistry, receptor concepts, dose-response relationships

    Drug designing: molecular modeling, computational chemistry, receptor concepts, dose-response relationships
    • Introduction to Drug Design

      Drug design involves the creation of new medications based on the knowledge of biological targets. It encompasses a variety of strategies to identify drug candidates with high efficacy and safety.

    • Molecular Modeling

      Molecular modeling employs computational techniques to represent the molecular structure of compounds. It helps in predicting the interactions between drug molecules and biological targets which is critical for drug optimization.

    • Computational Chemistry

      Computational chemistry uses computer simulations to assist in solving chemical problems. It supports drug design by allowing researchers to model chemical reactions, predict drug behaviors, and analyze the molecular properties.

    • Receptor Concepts

      Receptors are proteins that bind to specific molecules, triggering a biological response. Understanding receptor mechanisms is fundamental in drug design for developing molecules that can effectively target these receptors.

    • Dose-Response Relationships

      Dose-response relationships describe how the effect of a drug changes with varying doses. This concept is crucial for determining the optimal dose for achieving the desired therapeutic effect while minimizing adverse effects.

    • Case Studies in Drug Design

      This section reviews notable case studies where molecular modeling and computational chemistry significantly contributed to the discovery and development of successful pharmaceuticals.

  • Drug metabolism: phase I and II reactions, cytochrome P450 system, oxidation, reduction, conjugation

    Drug metabolism: phase I and II reactions, cytochrome P450 system, oxidation, reduction, conjugation
    • Introduction to Drug Metabolism

      Drug metabolism refers to the biochemical modification made by an organism on a chemical compound. It is essential for detoxifying drugs and facilitating their excretion.

    • Phase I Reactions

      Phase I reactions involve the introduction or exposure of functional groups on the drug molecule. These reactions primarily include oxidation, reduction, and hydrolysis. They are often catalyzed by enzymes such as cytochrome P450.

    • Phase II Reactions

      Phase II reactions involve conjugation, where drug metabolites are linked to another substance (like glucuronic acid, sulfate, or glutathione) to enhance their solubility and promote excretion.

    • Cytochrome P450 System

      The cytochrome P450 system is a family of enzymes involved in phase I metabolism, predominantly functioning in the liver. These enzymes play a crucial role in the oxidation of organic substances, leading to the activation or inactivation of drugs.

    • Oxidation Reactions

      Oxidation is a common phase I reaction where electrons are removed from the drug molecule. This process often makes the drug more polar, thus facilitating its excretion.

    • Reduction Reactions

      Reduction reactions are the opposite of oxidation. They involve the addition of electrons or hydrogen to the drug, which can convert an inactive drug to an active form.

    • Conjugation Reactions

      Conjugation is a phase II process where drug metabolites are bonded to another molecule to increase their water solubility. This step is critical for the excretion of the drug from the body.

  • Toxicology: mechanisms of toxicity, toxico-kinetics, target organ toxicity, heavy metals, environmental toxicants

    Toxicology
    • Mechanisms of Toxicity

      Toxicity can occur through various mechanisms, including cellular damage, disruption of cellular signaling, and direct alterations to biochemical pathways. Common mechanisms involve reactive oxygen species production, enzyme inhibition, and interference with cell membranes.

    • Toxico-kinetics

      Toxico-kinetics illustrates how toxic substances are absorbed, distributed, metabolized, and eliminated by the body. Factors affecting toxico-kinetics include route of exposure, chemical properties, and individual biological variations.

    • Target Organ Toxicity

      Different toxicants have specific target organs where they exert their effects. Common target organs include the liver, kidneys, nervous system, and lungs. Understanding target organ toxicity helps in risk assessment and management.

    • Heavy Metals

      Heavy metals such as lead, mercury, and cadmium are significant environmental contaminants. They can induce toxicity through various pathways, causing neurotoxicity, kidney damage, and disruption of metabolic processes.

    • Environmental Toxicants

      Environmental toxicants include pesticides, herbicides, and industrial chemicals that can have harmful effects on health and ecosystems. Their impact is assessed through exposure studies and toxicological evaluations.

  • Drug interactions, antidotes and management of poisoning, principles of diagnosis and treatment

    Drug interactions, antidotes and management of poisoning, principles of diagnosis and treatment
    • Drug Interactions

      Drug interactions occur when the effects of one drug are altered by the presence of another drug, food, or drink. These interactions can enhance or diminish drug effects, leading to side effects or therapeutic failures. Types of drug interactions include pharmacokinetic (absorption, distribution, metabolism, excretion) and pharmacodynamic (effects on the body). Awareness and management of potential interactions are crucial in clinical practice.

    • Antidotes

      Antidotes are substances that counteract the effects of poisons or toxins. They work through various mechanisms, such as binding to the toxin or reversing its effects. Examples include activated charcoal, naloxone for opioid overdose, and acetylcysteine for acetaminophen toxicity. The choice of antidote depends on the specific toxin involved, and timely administration is critical for effective management.

    • Management of Poisoning

      Management of poisoning involves several steps including initial assessment, stabilization, decontamination, antidote use, and supportive care. The approach is guided by the nature of the poison and the severity of the symptoms. Prompt recognition of symptoms and appropriate intervention can greatly reduce morbidity and mortality associated with poisoning.

    • Principles of Diagnosis

      Diagnosis of poisoning involves a thorough history taking, physical examination, and appropriate laboratory tests. The history should include information on potential exposure sources, amount, and time of exposure. Symptoms can vary widely depending on the substance involved. A systematic approach is required to identify the toxin and any resultant complications.

    • Principles of Treatment

      Treatment principles focus on eliminating the toxin, preventing further absorption, and providing symptomatic and supportive care. Approaches may include gastric lavage, activated charcoal, intravenous fluids, and specific antidotes. Monitoring may be necessary to assess the patient's response and to address complications. Multidisciplinary collaboration can enhance outcomes in cases of severe poisoning.

  • Preclinical toxicological studies, LD50 and ED50 determinations

    Preclinical toxicological studies, LD50 and ED50 determinations
    • Introduction to Preclinical Toxicology

      Preclinical toxicological studies are essential for evaluating the safety of new pharmaceutical compounds before clinical trials. These studies help identify potential toxic effects and establish safe dosage ranges.

    • Importance of Preclinical Studies

      Preclinical studies are performed to assess the pharmacokinetics, pharmacodynamics, and toxicology of a drug candidate. They help in characterizing the drug's safety profile and guide the design of clinical studies.

    • Types of Preclinical Toxicology Studies

      Common types of preclinical toxicology studies include acute toxicity, subacute toxicity, chronic toxicity, genotoxicity, reproductive toxicity, and carcinogenicity assessments. Each type has specific protocols and endpoints to evaluate drug safety.

    • LD50 Determination

      LD50, or the lethal dose for 50% of the population, is a standard measure used to assess the acute toxicity of a substance. LD50 values are determined through animal studies and help classify compounds based on their toxicity.

    • Mechanism of LD50 Assessment

      LD50 is assessed typically through oral, dermal, or inhalation exposure in laboratory animals. The results help establish dosage thresholds for safety evaluations.

    • ED50 Determination

      ED50, or the effective dose for 50% of the population, is a measure used to evaluate the efficacy of a drug in producing a desired therapeutic effect. It is crucial for determining optimal dosing regimens.

    • Importance of LD50 and ED50 in Drug Development

      Understanding LD50 and ED50 is vital for risk assessment, regulatory submissions, and making informed decisions during drug development. They inform dosage selection and safety margins.

    • Regulatory Considerations

      Regulatory agencies require comprehensive toxicological data, including LD50 and ED50 values, as part of the drug approval process to ensure patient safety.

Pharmaceutical Biochemistry and Toxicology

M.Sc. Medical Biochemistry

Pharmaceutical Biochemistry and Toxicology

III

Tamil Nadu State Council for Higher Education

Core VIII

free web counter

GKPAD.COM by SK Yadav | Disclaimer